Design
Editorial
Authors
Loading...
The authors advocate against the use of hydroxyethyl starch formulations due to significant safety concerns, challenging the EMA's decision to permit continued use in some patients.
The authors advocate against the use of hydroxyethyl starch formulations due to significant safety concerns, challenging the EMA's decision to permit continued use in some patients.
Hartog et al. (2014) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: